Vaccination with CpG-adjuvanted avian influenza virosomes promotes antiviral immune responses and reduces virus shedding in chickens

Viral Immunology

Volumn 25, Issue 3, 2012, Pages 226-231

  Mallick, Amirul I ^a   Kulkarni, Raveendra R ^a   St Paul, Michael ^a   Parvizi, Payvand ^a   Nagy, Éva ^a   Behboudi, Shahriar ^b   Sharif, Shayan ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AVIAN INFLUENZA VACCINE; AVIAN INFLUENZA VIRUS A H4N6 VIROSOME VACCINE; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INTERFERON; RECOMBINANT GAMMA INTERFERON; UNCLASSIFIED DRUG; VIROSOME;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIVIRAL ACTIVITY; ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; AVIAN INFLUENZA VIRUS A H4N6; CHICKEN; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNIZATION; NONHUMAN; TREATMENT OUTCOME; VIRUS SHEDDING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHICKENS; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; INFLUENZA VACCINES; OLIGODEOXYRIBONUCLEOTIDES; POULTRY DISEASES; VACCINATION; VACCINES, VIROSOME; VIRUS SHEDDING;

EID: 84862252632     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2011.0085     Document Type: Article

References (33)

1. Abdul-Careem MF, Hunter BD, Sarson AJ, Mayameei A, Zhou H, and Sharif S: Marek's disease virus-induced transient paralysis is associated with cytokine gene expression in the nervous system. Viral Immunol 2006;19:167-176. (Pubitemid 44050315)
2. Abdul-Careem MF, Hunter BD, Lee LF, et al.: Host responses in the bursa of Fabricius of chickens infected with virulent Marek's disease virus. Virology 2008;379:256-265.
3. Abrahamyan A, Nagy E, and Golovan SP: Human H1 promoter expressed short hairpin RNAs (shRNAs) suppress avian influenza virus replication in chicken CH-SAH and canine MDCK cells. Antiviral Res 2009;84:159-167.
4. Almeida JD, Edwards DC, Brand CM, and Heath TD: Formation of virosomes from influenza subunits and liposomes. Lancet 1975;2:899-901.
5. Bagai S, and Sarkar DP: Reconstituted Sendai virus envelopes as biological carriers: dual role of F protein in binding and fusion with liver cells. Biochim Biophys Acta 1993;1152: 15-25. (Pubitemid 23299030)
6. Barrett AD, and Gould EA: Antibody-mediated early death in vivo after infection with yellow fever virus. J Gen Virol 1986;67:2539-2542. (Pubitemid 17179549)
7. Bovier PA: Epaxal: a virosomal vaccine to prevent hepatitis A infection. Expert Rev Vaccines. 2008;7:1141-1150.
8. Brownlie R, Zhu J, Allan B, Mutwiri GK, Babiuk LA, Potter A, and Griebel P: Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides. Mol Immunol 2009;46:3163-3170.
9. Bublot M, Pritchard N, Cruz JS, Mickle TR, Selleck P, and Swayne DE: Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge. Avian Dis 2007;51:498-500. (Pubitemid 46671342)
10. Choi, Y. K., H. Ozaki, R. J. Webby, et al.: Continuing evolution of H9N2 influenza viruses in Southeastern China. J Virol 2004;78:8609-8614. (Pubitemid 39025127)
11. Eckl-Dorna J, and Batista FD: BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation. Blood 2009;23: 3969-3977.
12. Fernandez-Sesma A: The influenza virus NS1 protein: inhibitor of innate and adaptive immunity. Infect Disord Drug Targets 2007;7:336-343.
13. Gomis S, Babiuk L, Godson DL, et al.: Protection of chickens against Escherichia coli infections by DNA containing CpG motifs. Infect Immun 2003;71:857-863. (Pubitemid 36150781)
14. Halstead SB: Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 2003;60:421-467.
15. Reynolds DL, and Maraqa AD: Protective immunity against Newcastle disease: the role of antibodies specific to Newcastle disease virus polypeptides. Avian Dis 2000;44:138-144. (Pubitemid 30166120)
16. Kodihalli S, Goto H, Kobasa DL, Krauss S, Kawaoka Y, and Webster RG: DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J Virol 1999;73:2094-2098. (Pubitemid 29098113)
17. Kreijtz JH, Suezer Y, van Amerongen G, et al.: Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1. J Infect Dis 2007;195:1598-1606. (Pubitemid 46799217)
18. Kunzi V, Klap JM, Seiberling MK, et al.: Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration. Vaccine 2009;27:3561-3567.
19. Lau LT, Banks J, Aherne R, et al.: Nucleic acid sequence-based amplification methods to detect avian influenza virus. Biochem Biophys Res Commun 2004;313:336-342. (Pubitemid 37543590)
20. Lehtoranta L, Villberg A, Santanen R, and Ziegler T: A novel, colorimetric neutralization assay for measuring antibodies to influenza viruses. J Virol Methods 2009;159: 271-276.
21. Mallick AI, Parvizi P, Read LR, Nagy E, Behboudi S, and Sharif S: Enhancement of immunogenicity of a virosome-based avian influenza vaccine in chickens by incorporating CpG-ODN. Vaccine. 2010;29:1657-1665.
22. Mallick AI, Haq K, Brisbin JT, Mian MF, Kulkarni RR, and Sharif S: Assessment of bioactivity of a recombinant chicken interferon-gamma expressed using a baculovirus expression system. J Interferon Cytokine Res 2010;31:493-500.
23. Markgraf K, Muller K, Ponimaskin EG, Rudolph M, Schmidt MF, and Herrmann A: Lipid composition of virosomes modulates their fusion efficiency with cryopreserved bull sperm cells. Cloning 2001;3:11-21. (Pubitemid 32524637)
24. Pierson TC, Xu Q, Nelson S, Oliphant T, Nybakken GE, Fremont DH, and Diamond MS: The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. Cell Host Microbe 2007;19:135-145. (Pubitemid 46554914)
25. Polack FP, Teng MN, Collins PL, et al.: A role for immune complexes in enhanced respiratory syncytial virus disease. J Exp Med 2002;196:859-865.
26. Pushko P, Tumpey TM, Van Hoeven N, et al.: Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza. Vaccine 2007;25:4283-4290. (Pubitemid 46646962)
27. Sasaki T, Isoda N, Soda K, et al.: Evaluation of the potency, optimal antigen level and lasting immunity of inactivated avian influenza vaccine prepared from H5N1 virus. Jpn J Vet Res 2009;56:189-198.
28. Swayne DE, and Suarez DL: Highly pathogenic avian influenza. Rev Sci Tech 2000;19:463-482.
29. Takeda K, and Akira SL, et al.: Roles of Toll-like receptors in innate immune responses. Genes to Cells 2001;6:733-742. (Pubitemid 32894068)
30. Tumpey TM, Kapczynski DR, and Swayne DE: Comparative susceptibility of chickens and turkeys to avian influenza A H7N2 virus infection and protective efficacy of a commercial avian influenza H7N2 virus vaccine. Avian Dis 2004;48: 167-176. (Pubitemid 38448588)
31. Wang Y, Shan C, Ming S, Liu Y, Du y, and Jiang G: Immunoadjuvant effects of bacterial genomic DNA and CpG oligodeoxynucleotides on avian influenza virus subtype H5N1 inactivated oil emulsion vaccine in chicken. Res Vet Sci 2009;86:399-405.
32. Wilschut J: Influenza vaccines: the virosome concept. Immunol Lett 2009;122:118-121.
33. Wong JP, Christopher ME, Viswanathan S, et al.: Activation of toll-like receptor signaling pathway for protection against influenza virus infection. Vaccine 2009;27:3481-3483.